Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
LEGN
LEGN News & Events
-
Add to Watchlist
Trade LEGN
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
LEGN News
Deutsche Bank Downgrades Qiagen to Hold, Raises Price Target to $54
Jan 22 2026
Benzinga
Johnson & Johnson Exceeds Earnings Expectations and Raises Forecast Despite Share Decline
Jan 20 2026
Barron's
FDA Draft Guidance Boosts Arcellx (ACLX) and Legend Biotech (LEGN) Stock Prices
Jan 20 2026
seekingalpha
Healthcare Sector Outperforms S&P 500 with 12.52% Gain and 3.20 Health Score
Jan 14 2026
seekingalpha
Initial Week of LEGN Options Trading for August 2026
Dec 19 2025
NASDAQ.COM
Legend Biotech CEO to Present Latest Updates at J.P. Morgan Conference
Dec 17 2025
Globenewswire
Eight Stock Selections to Capitalize on a Robust Sector of the Market
Dec 11 2025
MarketWatch
Cancer Research Boosts Confidence in These Small Biotech Companies
Dec 09 2025
Barron's
Show More News
LEGN Events
01/21 12:10
Legend Biotech Shares Down 12.7% to $20.45
Legend Biotech is down -12.7%, or -$2.97 to $20.45.
01/21 10:10
Legend Biotech Shares Drop 10.5% to $20.96
Legend Biotech is down -10.5%, or -$2.46 to $20.96.
Show More Events
LEGN Monitor News
Legend Biotech Downgraded Amid Market Optimism for FDA Guidance
Jan 22 2026
FDA Guidance Boosts Legend Biotech's Market Prospects
Jan 21 2026
Legend Biotech Corp Hits 52-Week Low Amid Market Weakness
Dec 09 2025
Legend Biotech Corp Hits 52-Week Low Amid Market Weakness
Dec 08 2025
LEGN.O Shares Drop as 5-Day SMA is Crossed
Nov 24 2025
LEGN Earnings Analysis
Legend Biotech Earnings: CARVYKTI® Drives Growth- Intellectia AI™
2 months ago
Legend Biotech Corporation Reports Third Quarter 2024 Financial Results
1 years ago
People Also Watch